about
Skp2B attenuates p53 function by inhibiting prohibitinRegulation of RAF activity by 14-3-3 proteins: RAF kinases associate functionally with both homo- and heterodimeric forms of 14-3-3 proteinsCharacterization of PHB1 and its role in mitochondrial maturation and yolk platelet degradation during development of Artemia embryosThe aberrant expression and localization of prohibitin during apoptosis of human cholangiocarcinoma Mz-ChA-1 cellsA novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulationS-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liverDynamic change of Prohibitin2 expression in rat sciatic nerve after crush.Changes in protein expression in the rat medial vestibular nuclei during vestibular compensation.Distinct pigmentary and melanocortin 1 receptor-dependent components of cutaneous defense against ultraviolet radiation.Alkylation of prohibitin by cyclohexylphenyl-chloroethyl urea on an aspartyl residue is associated with cell cycle G(1) arrest in B16 cells.Positional and expressive alteration of prohibitin during the induced differentiation of human hepatocarcinoma SMMC-7721 cellsDifferential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis.Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cellsPseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expressionComparative genome analysis of PHB gene family reveals deep evolutionary origins and diverse gene function.β-catenin induces expression of prohibitin gene in acute leukemic cellsLocalization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid.Cancer models in Caenorhabditis elegans.Identification of prohibitin and prohibiton as novel factors binding to the p53 induced gene 3 (PIG3) promoter (TGYCC)(15) motif.Proteomic changes in the rat brain induced by homogenous irradiation and by the bystander effect resulting from high energy synchrotron X-ray microbeams.Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in miceRoles of prohibitin in growth control and tumor suppression in human cancersNuclear cytoplasmic trafficking of proteins is a major response of human fibroblasts to oxidative stressProteomic profile in glomeruli of type-2 diabetic KKAy mice using 2-dimensional differential gel electrophoresis.Proteomic analysis of anti-tumor effects of 11-dehydrosinulariolide on CAL-27 cells.Physical association of Arabidopsis hypersensitive induced reaction proteins (HIRs) with the immune receptor RPS2.Association of membrane rafts and postsynaptic density: proteomics, biochemical, and ultrastructural analyses.Protein changes in the retina following experimental retinal detachment in rabbits.Prohibitin Is Involved in Patients with IgG4 Related Disease.BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells.Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosisProhibitin as a novel autoantigen in rheumatoid arthritis.BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner.Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.Biochemical studies of the lagunamides, potent cytotoxic cyclic depsipeptides from the marine cyanobacterium Lyngbya majuscula.Comparison of Helicobacter bilis-Associated Protein Expression in Huh7 Cells Harbouring HCV Replicon and in Replicon-Cured CellsMultifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy.Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cellsProhibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondriaProhibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes.
P2860
Q24298517-9FE89B4B-454C-4793-A0CD-55277DF5B35AQ24320264-DF806C60-854B-42A0-A2BE-D13DB491B0E0Q27341797-10F062B4-508A-45BC-B8DA-26E2A44E22EAQ28118981-379349BF-3405-40C4-91A9-1CD69839427AQ28269042-76016AFB-3A1D-4C7D-B7C2-D33BC0051FCCQ28577149-67355A2F-881A-4DF4-9543-6B922431F84EQ30273967-7A6CE3F7-C0B3-4002-994C-311F17C878ADQ33249153-06140D36-A402-45DB-8378-09A983C25934Q33269159-962EF55C-9B94-4A23-B9E7-F720EA3B7E1BQ33294410-DF49617A-67A2-4198-95BC-F38C41C661E5Q33365586-0E704381-4227-4D74-B4F4-7745883D84A1Q33613931-255C582C-C939-42CE-B4A1-11AC19C29AE9Q33664289-C58EF4D8-908C-4C9E-90D9-D95B9E179F94Q33710018-E8C9A168-4220-4903-A1A0-365923461BFDQ33718588-4307DBC5-7442-4657-A507-538DF3C7AFBBQ33721147-2F2CA953-09A2-4068-B080-0CFCF2E0893BQ33742330-17CA7629-0FB7-4B63-A921-1B573CDEF564Q33903791-9B1C78E2-CBCF-48C9-8832-44E5CC95A735Q34138144-E629DEB5-6E44-4A85-9A01-7E8415F99A06Q34419688-2A836E18-249F-43EA-B63B-4A8A75C0B2F0Q34420616-5A363566-71A5-42B4-BC8C-CBEBDA6EDCBFQ34497715-C7828792-9EB7-4CE5-90AC-17311237F7C4Q34651070-7870F54D-E7AA-4DA4-A0BB-A9C4A9273204Q34783098-8A962CF7-7E24-4ECE-9DC5-3F0EBF40D2C2Q35142085-F11FE214-3762-4AEC-BB93-77F48C20D6D9Q35213150-C68D7422-B6E1-421D-A3F9-240607B1E027Q35249037-F4760EBA-3C4D-4571-9905-3F960D3E74D0Q35531768-7BD433B6-610B-4A3C-9808-2CB8E66817E7Q35561141-0D96DF0D-8804-4DD3-93E4-7F4FDB256E33Q35656014-8D9AB3C0-3AD3-4658-8ACD-9BE1EEED54B0Q35737753-8F8CA26B-CD28-40CF-8F1A-F9C285694408Q35756313-45846B01-D7BB-44A8-86D9-A6DD90AFE5F8Q35781362-551E0794-138B-4539-95B6-8A0C1209D052Q35796255-7FC65DEE-143D-4414-85CB-3E0692BA699DQ36096741-18728AB6-529C-4CCB-9D05-F9AD18A5DD3EQ36147887-2DA85DFB-CE3E-41E1-AADD-9593AD8870B0Q36291372-700C74F6-BD99-4F49-80A2-E73D36B130B7Q36347268-E97B328D-012B-481B-8E97-F30008A1D81CQ36453541-9F29D714-FC5D-44BE-B15F-7212958D0E6BQ36514204-FD83877B-4179-4D9A-97E7-8E408E7CADEC
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Prohibitin: a potential target for new therapeutics
@ast
Prohibitin: a potential target for new therapeutics
@en
Prohibitin: a potential target for new therapeutics
@nl
type
label
Prohibitin: a potential target for new therapeutics
@ast
Prohibitin: a potential target for new therapeutics
@en
Prohibitin: a potential target for new therapeutics
@nl
prefLabel
Prohibitin: a potential target for new therapeutics
@ast
Prohibitin: a potential target for new therapeutics
@en
Prohibitin: a potential target for new therapeutics
@nl
P2093
P1476
Prohibitin: a potential target for new therapeutics
@en
P2093
B L Gregoire Nyomba
Leigh C Murphy
Liam J Murphy
Suresh Mishra
P356
10.1016/J.MOLMED.2005.02.004
P407
P577
2005-04-01T00:00:00Z